2 天
GlobalData on MSNEMA to review GSK’s Nucala for COPD treatment expansionThe EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.
Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...
Despite its established use in other conditions, the antibody is not yet approved for COPD treatment in any nation. The mepolizumab programme of the company in COPD includes three studies ...
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and closer collaboration between healthcare professionals.
Oxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and bloodstream. Research suggests that people with chronic obstructive pulmonary disease (COPD) who use oxygen may ...
Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. The ...
This health education program aims to help patients living with COPD experience better health outcomes and improved quality ...
New data from Public Health Scotland estimates that the amount of people with chronic obstructive pulmonary disease (COPD) in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果